![Clive Stanway](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clive Stanway
Direktor/Vorstandsmitglied bei
Atelerix Ltd.
Profil
Clive Stanway is the founder of Stroma Biosciences Ltd. founded in 2020, where he holds the title of Director-Drug Discovery.
He is currently a Director at Atelerix Ltd. since 2018 and an Advisor at 4BIO Ventures Management Ltd. He previously held the position of Principal at Xenova Group Plc and Prolifix Ltd. and was the Chief Scientific Officer at Cancer Research Technology Ltd. Dr. Stanway holds a doctorate from Imperial College London and an undergraduate degree from The University of Nottingham.
Aktive Positionen von Clive Stanway
| Unternehmen | Position | Beginn |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | Berater | - |
Atelerix Ltd.
 Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Engages in preserving the viability and functionality of cells at hypothermic temperatures | Direktor/Vorstandsmitglied | 21.07.2018 |
Ehemalige bekannte Positionen von Clive Stanway
| Unternehmen | Position | Ende |
|---|---|---|
Stroma Biosciences Ltd.
 Stroma Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharma company for cancer therapy | Gründer | - |
Prolifix Ltd.
 Prolifix Ltd. Miscellaneous Commercial ServicesCommercial Services Operates in the pharmaceutical research and development sector | Corporate Officer/Principal | - |
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Develops cancer therapeutics, vaccines, and diagnostics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Clive Stanway
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolifix Ltd.
Prolifix Ltd. Miscellaneous Commercial ServicesCommercial Services Operates in the pharmaceutical research and development sector | Commercial Services |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Develops cancer therapeutics, vaccines, and diagnostics | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Engages in preserving the viability and functionality of cells at hypothermic temperatures | Electronic Technology |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | Finance |
Stroma Biosciences Ltd.
Stroma Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharma company for cancer therapy | Commercial Services |
